To present a case series of primary spinal chordoma patients and develop personalized therapeutic strategies tailored to each patient’s clinical status, focusing on surgical and adjunctive treatment options.
Key Findings:
Chordomas are rare tumors primarily located in the sacrum and spheno-occipital region.
Surgical resection is the mainstay of treatment, with en bloc resection being the preferred method for achieving disease-free survival.
Adjunctive radiotherapy may be crucial for controlling residual disease post-surgery and improving overall outcomes.
Interpretation:
The study emphasizes the need for tailored surgical approaches to balance maximal resection with the preservation of neurological function and quality of life, highlighting the importance of individualized treatment plans.
Limitations:
The study is retrospective and may be limited by the availability of comprehensive data.
Lack of established protocols for treatment strategies may affect the generalizability of findings.
Potential biases inherent in retrospective studies may influence the results.
Conclusion:
A personalized approach to the surgical management of spinal chordomas, supported by multidisciplinary collaboration, is essential for optimizing patient outcomes and addressing the unique challenges posed by these tumors.
Baptist Health Foundation announced that it has received a $2 million donation from Anthony and Joyce Esernia to establish a new endowed chair at Baptist Health Miami Neuroscience Institute.
